Surgery Partners recently announced its second-quarter 2026 financial results, revealing a clear strategic shift towards optimizing its core business. The company's leadership highlighted a portfolio restructuring, most notably the pending sale of its Idaho Falls facilities to Intermountain Health. This divestiture, valued at approximately $795 million, is a key component of their strategy to streamline operations, reduce debt, and concentrate on a pure-play short-stay surgical model. Despite this significant change, the company remains confident in its financial trajectory, reaffirming its full-year 2026 guidance for revenue between $3.35 billion and $3.45 billion, and adjusted EBITDA of at least $530 million, excluding the Idaho Falls impact.
Operationally, Surgery Partners has demonstrated robust performance in its continuing segments. Net revenue reached $848.9 million, an increase of 2.7% over the second quarter of 2025, with adjusted EBITDA at $125.2 million. The company's focus on high-acuity procedures, particularly in orthopedics, spine, and vascular services, has driven a 5% rise in same-facility revenue and a 4.8% increase in net revenue per case. Physician recruitment also remains a strong growth driver, with 191 new physicians joining in the second quarter, bringing the year-to-date total to 330. These new recruits are contributing significantly, with the 2026 cohort showing a nearly 16% increase in revenue compared to the previous year's cohort.
Looking ahead, Surgery Partners is poised for continued growth through internal development and strategic acquisitions. The company currently has six new facilities under construction and seven more in its development pipeline, underscoring its commitment to organic expansion. While M&A activity has been less prominent this year, management emphasized a disciplined approach, prioritizing strategic fit and long-term value. The Idaho Falls divestiture is expected to substantially reduce the company's exposure to complex acute care services, including inpatient pediatrics and nonsurgical admissions, allowing for a more focused and efficient operational profile. This strategic realignment aims to enhance cash conversion and support further deleveraging, reinforcing the company's financial stability and growth prospects in the evolving healthcare landscape.
Surgery Partners' strategic moves, including divesting non-core assets and prioritizing high-acuity surgical procedures, reflect a forward-thinking approach to healthcare delivery. By focusing on efficiency and specialized care, the company is not only strengthening its financial foundation but also enhancing its capacity to provide high-value, accessible surgical services. This proactive adaptation positions Surgery Partners to thrive amidst industry changes, demonstrating a commitment to innovation and patient-centered care.
